Stockholders’ Equity (Details Narrative) - USD ($)					3 Months Ended		12 Months Ended
	Mar. 22, 2023	Mar. 13, 2023	Mar. 09, 2023	Dec. 08, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Sep. 10, 2021	Dec. 31, 2016
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized					200,000,000		200,000,000
Preferred stock, shares authorized					10,000,000		10,000,000
Preferred stock, par value					$ 0.0001		$ 0.0001
Common stock par value	$ 0.0001				$ 0.0001		$ 0.0001
Aggregate offering price	$ 5,000,000
Commission rate	3.75%
Deposit expense	$ 15,000
Legal fees	50,000
Cost fees and expense	7,500
Cost fees and expense	$ 10,000
Shares issued for cash proceeds, net of offering costs, shares	5,000,000
Stock issued during period value new issues						$ 2,913,750
Marketing expense					$ 9,590
Share based compensation					$ 178,360	65,074
Weighted average vesting period					2 years 11 months 4 days
Intrinsic value option vested					$ 335,113
Intrinsic value outstanding					$ 335,113
Common stock equivalent outstaning percentage					94.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Net proceeds from issuance of common stock					$ 103,916	$ 2,913,750
Proceeds from issuance of private placement							$ 475,000
General and Administrative Expense [Member]
Subsidiary, Sale of Stock [Line Items]
Share based compensation					141,969
Share-Based Payment Arrangement, Option [Member]
Subsidiary, Sale of Stock [Line Items]
Stock based compensation expense					$ 1,375,931
Restricted Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares available for grant					328,124
Stock based compensation expense					$ 2,082,208
Stock based compensation expense period for recognition					3 years 8 months 8 days
Vesting period					3 years 8 months 8 days
Restricted Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Restricted common shares					21,876
2016 Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares available for grant								1,761,120		417,120
2021 Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares available for grant					635,622				900,000
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued for cash proceeds, net of offering costs, shares						630,000
Stock issued during period value new issues						$ 63
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture					6,700
Remaining fair value of the common stock					$ 87,910
Common Stock [Member] | Marketing Services Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued for cash proceeds, net of offering costs, shares			50,000
Stock issued during period value new issues			$ 97,500
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture					6,700
Common Stock [Member] | Founders Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued for cash proceeds, net of offering costs, shares		167,566
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Intrinsic value outstanding					$ 159,120
ATM Facility [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of stock number of shares issued in transaction					50,000
Sale of stock, consideration received on transaction					$ 103,916
Amortized deferred offering costs					$ 2,593
Nexcella [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of stock number of shares issued in transaction				350,000	100,152		73,188
Share price				$ 6.49	$ 6.49		$ 6.49
Net proceeds from issuance of common stock				$ 2,271,500	$ 650,000		$ 475,000
Nexcella [Member] | Chief Executive Officer [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds of funds held in subsidiary private offering					$ 50,000
Nexcella [Member] | Common Stock [Member] | 2022 Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period					1,125,000
Nexcella [Member] | Common Stock [Member] | 2022 Plan [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued for cash proceeds, net of offering costs, shares					375,000
Shares, Issued					25,000
Nexcella [Member] | Common Stock [Member] | 2022 Plan [Member] | Maximum [Member] | Board of Directors Chairman [Member]
Subsidiary, Sale of Stock [Line Items]
Stock Issued During Period, Shares, Acquisitions					1,125,000
Private Placement [Member] | Chief Executive Officer [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of stock number of shares issued in transaction					7,704
Private Placement [Member] | Chief Financial Officer [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of stock number of shares issued in transaction					15,408
Proceeds of funds held in subsidiary private offering					$ 100,000